Patents by Inventor Wayne E. Childers

Wayne E. Childers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040127505
    Abstract: Compounds of the formula 1
    Type: Application
    Filed: December 12, 2003
    Publication date: July 1, 2004
    Applicant: Wyeth
    Inventors: Wayne E. Childers, Michael G. Kelly, Lee E. Schechter, Sharon J. Rosenzweig-Lipson
  • Patent number: 6696450
    Abstract: Compounds of the formula have a long duration of action and are useful for the treatment of chronic diseases resulting from the dysfunction of the serotonergic 5-HT1A system, such as schizophrenia and other psychotic disorders such as paranoia and mano-depressive illness.
    Type: Grant
    Filed: April 2, 2002
    Date of Patent: February 24, 2004
    Assignee: Wyeth
    Inventors: Wayne E. Childers, Michael G. Kelly, Lee E. Schechter, Sharon J. Rosenzweig-Lipson
  • Publication number: 20030216408
    Abstract: Novel piperazine derivatives are provided having the formula 1
    Type: Application
    Filed: May 20, 2003
    Publication date: November 20, 2003
    Applicant: Wyeth
    Inventors: Wayne E. Childers, Michael G. Kelly, Sharon J. Rosenzweig-Lipson
  • Publication number: 20030191135
    Abstract: Compounds of the formula 1
    Type: Application
    Filed: April 2, 2002
    Publication date: October 9, 2003
    Applicant: Wyeth
    Inventors: Wayne E. Childers, Michael G. Kelly, Lee E. Schechter, Sharon J. Rosenzweig-Lipson
  • Publication number: 20030139449
    Abstract: This invention relates to compounds which have activity as 5-HT1A agonists and antagonists which may be useful for the treatment of anxiety, depression, cognitive deficits, and prostate cancer, having the formula 1
    Type: Application
    Filed: January 10, 2003
    Publication date: July 24, 2003
    Applicant: Wyeth
    Inventors: Wayne E. Childers, Michael G. Kelly, Yvette L. Palmer, Edward J. Podlesny
  • Patent number: 6586436
    Abstract: Novel piperazine derivatives are provided having the formula wherein R1 is cyano, nitro, trifluoromethyl or halogen, or pharmaceutically acceptable acid addition salts thereof, which are useful as 5-HT1A receptor antagonists.
    Type: Grant
    Filed: August 14, 2002
    Date of Patent: July 1, 2003
    Assignee: Wyeth
    Inventors: Wayne E. Childers, Michael G. Kelly, Sharon J. Rosenzweig-Lipson
  • Publication number: 20030092753
    Abstract: Adatanserin is useful for treating neurodegenerative disorders, chronic pain, and other disorders associated with dysfunctional glutamate release. Methods of treating the same comprise administering a therapeutically effective amount of adatanserin or a pharmaceutical salt thereof, to a patient in need of said treatment.
    Type: Application
    Filed: August 26, 2002
    Publication date: May 15, 2003
    Applicant: Wyeth
    Inventors: Magid A. Abou-Gharbia, James E. Barrett, Wayne E. Childers, John A. Moyer
  • Patent number: 6518272
    Abstract: This invention relates to compounds which have activity as 5-HT1A agonists and antagonists which may be useful for the treatment of anxiety, depression, cognitive deficits, and prostate cancer, having the formula wherein: X is a moiety selected from the group of: n is selected from the integers 1 through 5; R1 is optionally substituted aryl or mono or bicyclic heteroaryl, with a proviso that heteroaryl is not thiadiazole; R2 is H or alkyl; R3 is H, COR5, COOR5, and CONR5R6; R4 is H, alkyl, alkenyl, alkynyl, aryl, mono or bicyclic heteroaryl, aralkyl, and mono or bicyclic heteroaralkyl, wherein the aryl or heteroaryl groups are optionally substituted; R5 and R6 are H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, adamantyl, and noradamantyl or R5 and R6 taken together may form a 5-7 membered azacyclic ring, optionally containing an additional heteroatom selected from O, S, or NR4; when R5 or R6 are chosen from cycloalkyl or cycloalkenyl, the cyclic group may optionally
    Type: Grant
    Filed: March 27, 2002
    Date of Patent: February 11, 2003
    Assignee: Wyeth
    Inventors: Wayne E. Childers, Michael G. Kelly, Yvette L. Palmer, Edward J. Podlesny
  • Publication number: 20030022901
    Abstract: Novel piperazine derivatives are provided having the formula 1
    Type: Application
    Filed: August 14, 2002
    Publication date: January 30, 2003
    Applicant: Wyeth
    Inventors: Wayne E. Childers, Michael G. Kelly, Sharon J. Rosenzweig-lipson
  • Patent number: 6503928
    Abstract: Compounds of the formula wherein R1, R2, R3, R4, X and n are defined in the specification, are useful for the treatment of anxiety, depression and related CNS disorders, and other related conditions such as the treatment of alcohol and drug withdrawal, sexual dysfunction and Alzheimer's disease.
    Type: Grant
    Filed: September 18, 2001
    Date of Patent: January 7, 2003
    Assignee: Wyeth
    Inventors: Michael G. Kelly, Gan Zhang, Yvette L. Palmer, Wayne E. Childers
  • Publication number: 20020156075
    Abstract: This invention relates to compounds which have activity as 5-HT1A agonists and antagonists which may be useful for the treatment of anxiety, depression, cognitive deficits, and prostate cancer, having the formula 1
    Type: Application
    Filed: March 27, 2002
    Publication date: October 24, 2002
    Applicant: Wyeth (formerly American Home Products Corporation)
    Inventors: Wayne E. Childers, Michael G. Kelly, Yvette L. Palmer, Edward J. Podlesny
  • Patent number: 6469007
    Abstract: Novel piperazine derivatives are provided having the formula wherein R1 is cyano, nitro, trifluoromethyl or halogen, or pharmaceutically acceptable acid addition salts thereof, which are useful as 5-HT1A receptor antagonists.
    Type: Grant
    Filed: November 13, 2001
    Date of Patent: October 22, 2002
    Assignee: Wyeth
    Inventors: Wayne E. Childers, Michael G. Kelly, Sharon J. Rosenzweig-Lipson
  • Publication number: 20020107254
    Abstract: Novel piperazine derivatives are provided having the formula 1
    Type: Application
    Filed: November 13, 2001
    Publication date: August 8, 2002
    Applicant: American Home Products Corporation
    Inventors: Wayne E. Childers, Michael G. Kelly, Sharon J. Rosenzweig-Lipson
  • Patent number: 6376494
    Abstract: This invention relates to compounds which have activity as 5-HT1A agonists and antagonists which may be useful for the treatment of anxiety, depression, cognitive deficits, and prostate cancer, having the formula wherein: X is a moiety selected from the group of: n is selected from the integers 1 through 5; R1 is optionally substituted aryl or mono or bicyclic heteroaryl, with a proviso that heteroaryl is not thiadiazole; R2 is H or alkyl; R3 is H, COR5, COOR5, and CONR5R6; R4 is H, alkyl, alkenyl, alkynyl, aryl, mono or bicyclic heteroaryl, aralkyl, and mono or bicyclic heteroaralkyl, wherein the aryl or heteroaryl groups are optionally substituted; R5 and R6 are H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, adamantyl, and noradamantyl or R5 and R6 taken together may form a 5-7 membered azacyclic ring, optionally containing an additional heteroatom selected from O, S, or NR4; when R5 or R6 are chosen from cycloalkyl or cycloalkenyl, the cyclic group may optionally
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: April 23, 2002
    Assignee: American Home Products Corporation
    Inventors: Wayne E. Childers, Michael G. Kelly, Yvette L. Palmer, Edward J. Podlesny
  • Publication number: 20020035263
    Abstract: Compounds of the formula 1
    Type: Application
    Filed: September 18, 2001
    Publication date: March 21, 2002
    Applicant: American Home Products Corporation
    Inventors: Michael G. Kelly, Gan Zhang, Yvette L. Palmer, Wayne E. Childers
  • Publication number: 20020013324
    Abstract: Compounds of the Formula (I) 1
    Type: Application
    Filed: August 23, 2001
    Publication date: January 31, 2002
    Applicant: American Home Products Corporation
    Inventors: Wayne E. Childers, Michael G. Kelly, Gan Zhang, Yvette L. Palmer, Edward J. Podlesny
  • Patent number: 6326381
    Abstract: Compounds of the formula wherein R1, R2, R3, R4, X and n are defined in the specification, are useful for the treatment of anxiety, depression and related CNS disorders, and other related conditions such as the treatment of alcohol and drug withdrawal, sexual dysfunction and Alzheimer's disease.
    Type: Grant
    Filed: December 13, 1999
    Date of Patent: December 4, 2001
    Assignee: American Home Products Corporation
    Inventors: Michael G. Kelly, Gan Zhang, Yvette L. Palmer, Wayne E. Childers
  • Patent number: 6306859
    Abstract: Compounds of the Formula (I) wherein R2, Y, X and n are as defined in the specification which compounds are useful in the treatment of disorders associated with serotonergic neuron-related diseases.
    Type: Grant
    Filed: March 1, 2000
    Date of Patent: October 23, 2001
    Assignee: American Home Products Corporation
    Inventors: Wayne E. Childers, Michael G. Kelly, Gan Zhang, Yvette L. Palmer, Edward J. Podlesny
  • Patent number: 6239134
    Abstract: The present invention provides compounds of the general formula (1): wherein: two atoms of X, Y, or Z are nitrogen and the third atom is sulfur or oxygen; R is H, halogen, OH, SH, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 thioalkyl, phenoxy, thiophenoxy, phenyl or substituted phenyl; A is C, CH, or N; R1 is aryl, heteroaryl, or cycloalkyl groups, optionally substituted by from 1 to 3 substituents selected from C1-C6 alkyl, C1-C6 alkoxy; CF3, Cl, Br, F, CN, or CO2CH3; R2is H or alkyl R3 is C1-C6 alkyl, optionally substituted aryl, optionally substituted 5- or 6-membered heteroaryl, C3 to C8 cycloalkyl optionally substituted by C1-C6 alkyl, or a 3 to 8-membered heterocyclic ring containing one or more heteroatoms selected from O, S or N; or a pharmaceutically acceptable salt thereof, as well as pharmaceutical compositions and methods of treating central nervous system disorders using these compounds.
    Type: Grant
    Filed: February 25, 2000
    Date of Patent: May 29, 2001
    Assignee: American Home Products Corp.
    Inventors: Annmarie L. Sabb, Robert L. Vogel, Michael G. Kelly, Yvette L. Palmer, Wayne E. Childers
  • Patent number: 6110943
    Abstract: This invention provides compounds having the structure ##STR1## that are useful as antipsychotic, antidepressant and anxiolytic agents useful in the treatment and relief of the symptoms of these disease states.
    Type: Grant
    Filed: April 6, 1999
    Date of Patent: August 29, 2000
    Assignee: American Home Products Corporation
    Inventors: Reinhartd B. Baudy, Wayne E. Childers, Jr., Michael G. Kelly